A Phase 4 interventional study of Placebo and Tribulus terrestris in Sexual Functions and Problems in the Adult, sponsored by Faculdade de Ciências Médicas da Santa Casa de São Paulo. Completed at 1 site in Brazil. Open to female participants aged 40 Years to 70 Years. Per ClinicalTrials.gov, last updated 2015-11-10.
Sponsored by Faculdade de Ciências Médicas da Santa Casa de São Paulo · Phase 4, Interventional, and Treatment
Objective: To study the effects of Tribulus terrestris on sexuality in postmenopausal women.
Sexuality is an integral part of every personality, influence thoughts, feelings, actions, integrations, and therefore the physical and mental health. It is estimated that 43% of women have at least one complaint of sexual problem. Disorders of desire and arousal are among the most common problems found in gynecologic practice. Medicinal plants have been used for therapeutic purposes for thousands of years, and aphrodisiac properties described in several plants. Tribulus terrestris is a plant indigenous to India, recommended in the treatment of infertility, low libido and impotence, and its main active ingredient protodioscin (PTN).
126 studies on the registry are indexed under Sexual Dysfunction, Physiological; 45 are open to participants now.
This study's enrollment of 60 is close to the median of 60 across 88 interventional studies indexed under Sexual Dysfunction, Physiological.
Browse Sexual Dysfunction, Physiological studies →Faculdade de Ciências Médicas da Santa Casa de São Paulo is the lead sponsor of 41 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
1 tablet of placebo/ oral/ 3 times a day for three months
Drug: Placebo
1 tablet of 250mg/ oral/ 3 times a day for three months
Drug: Tribulus terrestris
1 tablet/ oral/ 3 times a day for 90 days
Also known as: lot 168159
1 tablet of 250mg/ oral/ 3 times a day for 90 days
Also known as: lot 168059
Sexual function in post-menopausal women
Based the questionnaires Golombok-Rust Inventory of Sexual Satisfaction (GRISS) and Sexual Quotient - female version (SQF).
Time frame: 90 days
Female Intervention Efficacy Index (FIEI)
Time frame: 3 months
This study is completed, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Tribulus extract
Sexual Dysfunction, Physiological →
Faculdade de Ciências Médicas da Santa Casa de São Paulo